900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
2019-nCoV detected	Acceptable (foundation metadata concept)
2019-nCoV immunization	Acceptable (foundation metadata concept)
2019-nCoV mRNA immunization	Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccination	Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccination not indicated	Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccine contraindicated	Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccine declined	Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector immunization	Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector vaccination	Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector vaccine contraindicated	Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector vaccine declined	Acceptable (foundation metadata concept)
2019-nCoV not detected	Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen immunization	Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen vaccination	Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen vaccine contraindicated	Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen vaccine declined	Acceptable (foundation metadata concept)
2019-nCoV vaccination	Acceptable (foundation metadata concept)
2019-nCoV vaccination not indicated	Acceptable (foundation metadata concept)
2019-nCoV vaccination not indicated	Acceptable (foundation metadata concept)
2019-nCoV vaccine contraindicated	Acceptable (foundation metadata concept)
2019-nCoV vaccine contraindicated	Acceptable (foundation metadata concept)
2019-nCoV vaccine declined	Acceptable (foundation metadata concept)
2019-nCoV vaccine declined	Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen immunization	Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen vaccination	Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen vaccine contraindicated	Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen vaccine declined	Acceptable (foundation metadata concept)
201m-Bi	Acceptable (foundation metadata concept)
201m-Pb	Acceptable (foundation metadata concept)
202-Bi	Acceptable (foundation metadata concept)
202-Pb	Acceptable (foundation metadata concept)
202-Tl	Acceptable (foundation metadata concept)
202m-Pb	Acceptable (foundation metadata concept)
203-Bi	Acceptable (foundation metadata concept)
203-Hg	Acceptable (foundation metadata concept)
203-Pb	Acceptable (foundation metadata concept)
203.6	Preferred (foundation metadata concept)
203.6 (qualifier value)	Preferred (foundation metadata concept)
204-Bi	Acceptable (foundation metadata concept)
204-Tl	Acceptable (foundation metadata concept)
204m-Pb	Acceptable (foundation metadata concept)
205-Bi	Acceptable (foundation metadata concept)
205-Pb	Acceptable (foundation metadata concept)
206-Bi	Acceptable (foundation metadata concept)
206-Tl	Acceptable (foundation metadata concept)
207-Bi	Acceptable (foundation metadata concept)
207-Tl	Acceptable (foundation metadata concept)
207m-Pb	Acceptable (foundation metadata concept)
208-Bi	Acceptable (foundation metadata concept)
208-Tl	Acceptable (foundation metadata concept)
208.333	Preferred (foundation metadata concept)
208.333 (qualifier value)	Preferred (foundation metadata concept)
209-Bi	Acceptable (foundation metadata concept)
209-Pb	Acceptable (foundation metadata concept)
209-Tl	Acceptable (foundation metadata concept)
20G	Preferred (foundation metadata concept)
20G (qualifier value)	Preferred (foundation metadata concept)
20M post incubation	Acceptable (foundation metadata concept)
20alpha-hydroxysteroid dehydrogenase	Acceptable (foundation metadata concept)
20p partial trisomy syndrome	Preferred (foundation metadata concept)
20p partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
20p subtelomeric deletion syndrome	Acceptable (foundation metadata concept)
20p12.2 deletion syndrome	Preferred (foundation metadata concept)
20p12.2 deletion syndrome (disorder)	Preferred (foundation metadata concept)
20p12.3 microdeletion syndrome	Preferred (foundation metadata concept)
20p12.3 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
20p12.3 microdeletion syndrome is a recently described syndrome characterized by Wolff-Parkinson-White syndrome, variable developmental delay and facial dysmorphism.	Preferred (foundation metadata concept)
20p13 microdeletion syndrome	Preferred (foundation metadata concept)
20p13 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
20p13 microdeletion syndrome is a rare chromosomal anomaly characterized by developmental delay, mild to moderate intellectual disability, epilepsy, and unspecific dysmorphic signs. High palate, delayed permanent tooth eruption, hypoplastic fingernails, clinodactyly and short fingers have also been reported.	Preferred (foundation metadata concept)
20q partial trisomy	Preferred (foundation metadata concept)
20q partial trisomy (disorder)	Preferred (foundation metadata concept)
20q11.2 microdeletion syndrome	Preferred (foundation metadata concept)
20q11.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
20q11.2 microduplication syndrome	Preferred (foundation metadata concept)
20q11.2 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
20q11.2 microduplication syndrome is a rare chromosomal anomaly syndrome, due to partial duplication of the long arm of chromosome 20, characterized by psychomotor and developmental delay, moderate intellectual disability, metopic ridging/trigonocephaly, short hands and/or feet and distinctive facial features (epicanthus, hypoplastic supraorbital ridges, horizontal/downslanting palpebral fissures, small nose with depressed nasal bridge and anteverted nostrils, prominent cheeks, retrognathia and small, thick ears). Growth delay and cryptorchidism are often associated features.	Preferred (foundation metadata concept)
20q13.33 microdeletion syndrome	Preferred (foundation metadata concept)
20q13.33 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
21	Preferred (foundation metadata concept)
21 (AJCC)	Acceptable (foundation metadata concept)
21 (UICC)	Acceptable (foundation metadata concept)
21 (qualifier value)	Preferred (foundation metadata concept)
21 DAY FLEA & TICK DIP	Preferred (foundation metadata concept)
21 DAY FLEA & TICK DIP (product)	Preferred (foundation metadata concept)
21 gene breast recurrence score	Preferred (foundation metadata concept)
21 gene breast recurrence score (observable entity)	Preferred (foundation metadata concept)
21-Hydroxylase antibody assay	Acceptable (foundation metadata concept)
21-Ne	Acceptable (foundation metadata concept)
21-deoxycorticosterone	Preferred (foundation metadata concept)
21-deoxycorticosterone (substance)	Preferred (foundation metadata concept)
21-deoxycortisol	Preferred (foundation metadata concept)
21-deoxycortisol (substance)	Preferred (foundation metadata concept)
21-hydroxylase	Acceptable (foundation metadata concept)
21-hydroxylase antibody	Acceptable (foundation metadata concept)
21-hydroxylase deficiency	Preferred (foundation metadata concept)
21-hydroxylase deficiency	Acceptable (foundation metadata concept)
21-hydroxylase deficiency (disorder)	Preferred (foundation metadata concept)
21-hydroxylase deficiency, salt wasting type	Acceptable (foundation metadata concept)
21-hydroxyprogesterone	Acceptable (foundation metadata concept)
21-hydroxysteroid dehydrogenase (NADP^+^)	Preferred (foundation metadata concept)

Start Previous Page 90 of 13262 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)